RFXAP

RFXAP is an essential subunit of the trimeric RFX transcription factor complex (with RFX5 and RFXB) that binds X-box elements in MHC class II gene promoters and is required for MHC class II gene expression (PMID:9118943, PMID:18723135). Its intrinsically disordered C-terminal domain folds upon binding the RFX5 N-terminal dimerization domain, forming a V-shaped α-helical structure packed within an antiparallel coiled-coil staple, which then enables high-affinity recruitment of RFXB and relief of RFX5 autoinhibition (PMID:19274739, PMID:20732328, PMID:18723135). Conserved hydrophobic and phosphorylatable C-terminal residues mediate isotype-specific CIITA recruitment, differentially coordinating HLA-DR, -DQ, and -DP expression (PMID:11486010, PMID:16337482). Loss-of-function mutations in RFXAP cause MHC class II deficiency (bare lymphocyte syndrome complementation group D), and RFXAP also directly activates transcription of the histone demethylase KDM4A, linking the RFX complex to chromatin remodeling and DNA damage responses (PMID:9118943, PMID:33093461).

1. 1997 High

   Identification of RFXAP as the gene defective in complementation group D of MHC class II deficiency established that a previously unknown RFX complex subunit is essential for MHC-II expression and RFX DNA-binding activity.

   Evidence Complementation cloning, mutation identification in patient cell lines, and transfection rescue restoring MHC-II expression

   PMID:9118943 PMID:9287230

   Open questions at the time

   • No structural information on RFXAP or its mode of incorporation into the RFX complex
   • Mechanism by which RFXAP contributes to DNA binding unknown
   • Relationship between RFXAP domains and function unresolved
2. 2001 High

   Domain mapping revealed that only the C-terminal segment of RFXAP is required for HLA-DR expression, while larger C-terminal regions are needed for HLA-DQ and -DP, demonstrating that RFXAP mediates isotype-specific promoter occupancy and CIITA recruitment.

   Evidence Deletion analysis with transfection rescue and in vivo ChIP/promoter occupancy assays in RFXAP-deficient cells

   PMID:11486010

   Open questions at the time

   • Identity of specific residues responsible for isotype selectivity not yet determined
   • Mechanism of differential CIITA recruitment unclear
3. 2005 High

   Site-directed mutagenesis pinpointed conserved hydrophobic residues and potential phosphorylation sites in the RFXAP C-terminus as essential for coordinate MHC-II expression and efficient CIITA recruitment, resolving which sequence features underlie isotype-specific transcription.

   Evidence Comparative genomics, site-directed mutagenesis, complementation rescue, ChIP for CIITA, chimeric reporter assays

   PMID:16337482

   Open questions at the time

   • Kinase(s) responsible for RFXAP phosphorylation not identified
   • Whether phosphorylation regulates RFXAP in vivo remains untested
4. 2008 High

   Biochemical reconstitution demonstrated that RFX5 DNA-binding activity is autoinhibited and that both RFXAP and RFXB are required to relieve autoinhibition, establishing the functional logic of the trimeric RFX complex.

   Evidence EMSA with recombinant RFX5 alone and in complex with RFXAP and RFXB

   PMID:18723135

   Open questions at the time

   • Structural basis of autoinhibition relief not resolved
   • Stoichiometry of the full complex on DNA not determined
5. 2009 High

   Biophysical studies revealed that the RFXAP C-terminal domain is intrinsically disordered but undergoes coupled folding-and-binding upon interacting with the RFX5 N-terminal dimer, and that this pre-formed subcomplex then recruits RFXB with high affinity, defining a hierarchical assembly pathway.

   Evidence NMR, circular dichroism, and isothermal titration calorimetry on recombinant domains

   PMID:19274739

   Open questions at the time

   • Full-length complex structure not available
   • Whether the hierarchical assembly occurs on or off DNA in cells unknown
6. 2010 High

   The solution NMR structure of the RFX5(N)₂–RFXAP(C) complex showed RFXAP-C adopting a V-shaped two-helix fold packed within an antiparallel coiled-coil staple formed by RFX5-N, with leucine residues at the interface critical for MHC-II expression in vivo.

   Evidence Solution NMR structure determination (¹⁵N/¹³C-edited) with in vivo validation of leucine point mutants

   PMID:20732328

   Open questions at the time

   • Structure of the full trimeric complex with RFXB not determined
   • How the structural interface connects to CIITA recruitment is unresolved
7. 2015 Medium

   Discovery that pancreatic cancer exosomes deliver miR-212-3p to dendritic cells to directly suppress RFXAP mRNA revealed a post-transcriptional mechanism by which tumors downregulate MHC-II expression for immune evasion.

   Evidence Exosome transfer assays, luciferase reporter validation of miR-212-3p targeting the RFXAP 3′-UTR, qRT-PCR and western blot in dendritic cells

   PMID:26337469

   Open questions at the time

   • Single lab study; independent replication lacking
   • In vivo relevance of miR-212-3p-mediated RFXAP suppression in patient tumors not established
8. 2020 Medium

   Identification of KDM4A as a direct transcriptional target of RFXAP expanded its functional scope beyond MHC-II regulation to chromatin remodeling and DNA damage responses.

   Evidence ChIP-seq showing RFXAP binding at the KDM4A promoter, dual-luciferase reporter assay, RFXAP overexpression/knockdown affecting H3K36me3 levels and DNA damage markers in pancreatic cancer cells and xenografts

   PMID:33093461

   Open questions at the time

   • Whether RFXAP acts at KDM4A as part of the canonical RFX complex or independently is unknown
   • Genome-wide identification of RFXAP transcriptional targets beyond MHC-II and KDM4A not performed

• A complete structural model of the full trimeric RFX–DNA complex, the identity of kinases phosphorylating RFXAP, and the genome-wide spectrum of RFXAP transcriptional targets remain unresolved.
• No full-length trimeric RFX complex structure on DNA
• Kinase(s) for RFXAP phosphorylation unidentified
• Genome-wide RFXAP target gene repertoire undefined